Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Adult Stem Cells

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pharmacological inhibition of myosin reduces the cytotoxic effect of a Lys49 PLA<sub>2</sub>-like myotoxin on human and rat cardiac muscle.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same author

Extracellular BRICK1 drives heart repair after myocardial infarction in mice.

Science translational medicine·2026

Same author

Increase in mechanical load and pro-fibrotic stimulation leads to fibrotic and hypertrophic remodeling in porcine living myocardial slices.

Scientific reports·2025

Same author

Different Pattern in Circulating MicroRNA-22-3p Levels Between Patients With Primary Versus Secondary Sarcopenia.

Aging cell·2025

Same author

Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy.

British journal of pharmacology·2025

Same author

The RNA-binding protein Quaking is essential for cardiac homeostasis and function by regulating Morf4l2 splicing.

Journal of molecular and cellular cardiology·2025

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Recent patents on cardiovascular stem cells.

Marten Jakob¹, Thomas Thum

¹Universitätsklinik, Medizinische Klinik I, Kardiologie, Würzburg, Germany.

Recent Patents on Cardiovascular Drug Discovery

|January 29, 2008

Summary

This review surveys patents for regenerative cardiovascular medicine, focusing on stem cell therapies and growth factors to improve heart function and blood vessel repair. It highlights methods for stem cell differentiation into cardiomyocytes for treating heart failure.

More Related Videos

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jul 8, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Area of Science:

Regenerative Medicine
Cardiovascular Science
Biotechnology

Background:

Chronic heart failure is a major global health burden.
Replacing scar tissue with viable myocardium and enhancing neovascularization can improve cardiac function.
Stem and progenitor cell therapies show promise for improving cardiac perfusion and contractility.

Purpose of the Study:

To review patent applications for cell-based and non-cell-based therapies in regenerative cardiovascular medicine.
To provide an overview of the current patent landscape in stem cell applications for cardiovascular diseases.
To aid future decision-making in developing novel therapeutic strategies.

Main Methods:

Systematic screening of patent databases.
Categorization of patents into cell-based therapies, growth factor applications, angiogenesis/vascular function improvements, and stem cell differentiation methods.
Review of patents related to generating cardiomyocytes from stem cells.

Main Results:

Identified various patent applications for cell-based therapies and growth factors to enhance cardiovascular function.
Cataloged patents focused on improving angiogenesis, re-endothelialization, and overall vascular function.
Detailed patents concerning enhanced differentiation of stem cells into cardiovascular cells, including cardiomyocytes.

Conclusions:

A comprehensive patent overview is crucial for advancing regenerative cardiovascular medicine.
Understanding the patent landscape facilitates the development of novel therapeutic strategies.
Stem cell-based approaches, including directed differentiation, are central to future cardiovascular regenerative therapies.